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Edited by Ulf-Ingo Flu¨ggeAbstract Paspaline belongs to a large, structurally and func-
tionally diverse group of indole-diterpenes synthesized by ﬁla-
mentous fungi. However, the identity of the gene products
required for the biosynthesis of paspaline, a key intermediate
for the synthesis of paxilline and other indole-diterpenes, is not
known. Transfer of constructs containing diﬀerent pax gene
combinations into a paxilline negative deletion derivative of Pen-
icillium paxilli demonstrated that just four proteins, PaxG, a
geranylgeranyl diphosphate synthase, PaxM, a FAD-dependent
monooxygenase, PaxB, a putative membrane protein, and PaxC,
a prenyl transferase, are required for the biosynthesis of paspa-
line.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Indole-diterpenes are a large, structurally diverse group of
natural products synthesized by ﬁlamentous fungi [1]. These
natural products share a common core structure comprised
of a cyclic diterpene skeleton derived from geranylgeranyl
diphosphate (GGPP) and an indole moiety derived from tryp-
tophan or a tryptophan precursor [2–6]. Further complexity of
the basic indole-diterpene ring structure occurs by additional
prenylations, diﬀerent ring substitutions and ring stereochem-
istry. These metabolites have a number of biological activities
including insect feeding deterrence, modulation of insect and
mammalian ion channels and inhibition of speciﬁc enzymes
[7,8]. The structural complexity and diverse biological activi-
ties of these compounds have attracted the attention of
synthetic chemists resulting in both total and biomimetic syn-
theses of a number of paxilline-like indole-diterpenes [9–15].
The results of these studies suggest that 3-geranylgeranylindole
is a common intermediate, which undergoes epoxidation
followed by cyclization to give indole-diterpenes. More
recently, feeding experiments with deuterium labeled 3-gera-*Corresponding author. Fax: +64 6 3505688.
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pound into paxilline and emindole DA [16]. Although
biosynthetic schemes have been proposed for paxilline-like
compounds none of the enzymes responsible for catalyzing
the proposed steps have been identiﬁed [6,17].
The cloning and characterization of a cluster of genes from
Penicillium paxilli necessary for biosynthesis of the indole-
diterpene, paxilline, has provided for the ﬁrst time an insight
into the gene products required for the synthesis of this
important class of natural products and their biochemical
function [18]. Systematic gene disruption and chemical com-
plementation studies have shown that at least ﬁve enzymes
are needed for paxilline biosynthesis [18,19]. paxG is pro-
posed to encode a GGPP synthase that catalyzes the synthe-
sis of GGPP, the determinant step in indole-diterpene
biosynthesis. Deletion mutants of paxM, encoding a FAD-
dependent monooxygenase (McMillan et al., unpublished re-
sults) and paxC, encoding a prenyl transferase (Young et al.,
unpublished results), lack the ability to synthesize any iden-
tiﬁable indole-diterpene indicating that these gene products
catalyze early steps in paxilline biosynthesis. By contrast
deletion of paxP, encoding a cytochrome P450 monooxygen-
ase, resulted in a mutant strain that accumulates paspaline
[19]. Taken together these results suggest that paspaline is
the ﬁrst stable indole-diterpene product, and that its synthe-
sis requires the action of three enzymes viz. PaxG, PaxM
and PaxC [20]. However, two additional genes, paxA and
paxB, were recently identiﬁed within the core cluster of
paxG–paxM–paxC–paxP–paxQ (Monahan et al., unpub-
lished results). Sequence analysis of PaxA and PaxB suggests
that these are polytopic membrane proteins containing seven
transmembrane domains. Deletion derivatives of paxA and
paxB were unable to synthesize any detectable indole-diter-
penes. However, neither protein has any identiﬁable enzy-
matic function. The identiﬁcation of these two new genes,
the absence of detectable indole-diterpenes in paxG, paxM
and paxC deletion mutants and accumulation of paspaline
in the paxP deletion mutant suggests that up to ﬁve proteins
PaxG, PaxA, PaxM, PaxB and PaxC are required for pasp-
aline biosynthesis in P. paxilli. The objectives of this study
were to deﬁne the minimum number of genes required for
the synthesis of paspaline and to propose a biosynthetic
scheme for the synthesis of this indole-diterpene. Our work-
ing hypothesis is that ﬁve gene products are required for
paspaline biosynthesis.blished by Elsevier B.V. All rights reserved.
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2.1. Bacterial strains and plasmids
Escherichia coli strain DH5a (Invitrogen) served as the host for
routine cloning. The transformants of this host were grown on LB
agar plates supplemented with ampicillin (100 lg/ml) for selection.
pGEM-T Easy (Promega) and pII99 plasmids were used for clon-
ing.2.2. Fungal strains and growth conditions
Cultures of wild-type P. paxilli Bainier (PN2013 = ATCC 26601)
and CY2 (PN2250) mutant derivatives were routinely grown in Asper-
gillus complete medium (ACM) [2% (w/v) malt extract (Oxoid, Basing-
stoke, England), 1% (w/v) mycological peptone (Oxoid), 2% (w/v)
glucose, 1.5% (w/v) agar] and ACM supplemented with 0.8 M sucrose
(RG medium), at 22 C for 4–6 days. Liquid cultures were started
using an inoculum of 5 · 106 spores per 25 ml of CDYE medium
[3.34% (w/v) Czapex-Dox (Oxoid), 0.5% (w/v) yeast extract] supple-
mented with 0.5% (v/v) trace element mix [in 0.6 N HCl: 0.05% (w/v)
FeSO4 Æ 7H2O, 0.05% (w/v) ZnSO4 Æ 7H2O, 0.01% (w/v) MnSO4 Æ H2O,
0.005% (w/v) CuSO4 Æ 5H2O, 0.004% (w/v) CoCl2 Æ 6H2O], and shaken
at 200 rpm at 28 C for 7 days. Media were supplemented with genet-
icin (150 lg/ml), where necessary.2.3. Molecular biology
Plasmid DNA was isolated and puriﬁed by alkaline lysis using either
a Bio-Rad Quantum Prep Plasmid Miniprep Kit (Bio-Rad Laborato-
ries, CA, USA) or High Pure Plasmid Isolation Kit (Roche Diagnos-
tics GmbH, Mannheim, Germany). Genomic DNA was isolated
using a modiﬁcation of the method of Yoder [21] as described previ-
ously [22]. Southern blotting and hybridization conditions were as de-
scribed previously [22]. Genomic DNA for PCR screening was
prepared from fungal spores. Spores from approximately
0.3 cm · 0.3 cm section of transformants on ACM were suspended in
1 ml TE (10 mM Tris–HCl, pH 7.5, 1 mM EDTA) with 0.01% (v/v)
Triton X-100. 100 ll spore suspension was transferred into a 2 ml mi-
cro-tube PP (Sarstedt, Germany) containing sterile glass beads (425-
600 lm). The spores were disrupted in a FastPrep Cell Disrupter
FP120 (Thermo Savant, NY, USA) for 20 s at 4 m/s and centrifuged
at 13000 rpm for 10 min. The supernatant was collected and a 5 ll
sample was used as the template for PCR. DNA fragments and PCR
products were puriﬁed using QIAquick Gel Extraction and PCR Puri-
ﬁcation Kit (Qiagen). DNA fragments were sequenced by the dide-
oxynucleotide chain-termination method [23] using Big-Dye (Version
3) chemistry (Perkin–Elmer Applied Biosystems, Foster City, CA,
USA) with oligonucleotide primers (Sigma Genosys). Products were
separated on an ABI Prism 377 sequencer (Perkin–Elmer Applied Bio-
systems).2.4. PCR conditions
PCR of paxM and paxM–paxB for cloning was carried out in 50 ll
reaction volume containing 5 ll of 10· reaction buﬀer (Roche Diag-
nostics GmbH, Penzberg, Germany), 200 lM of each dNTP, 300 nM
of each primer, 0.75 U of Expand High Fidelity Enzyme Mix (Roche)
and 10 ng of plasmid. PCR of paxA–paxM for cloning was carried out
in 50 ll reaction volume containing 5 ll of 10· reaction buﬀer (Triple-
Master PCR System, Eppendorf AG, Hamburg, Germany), 200 lM
of each dNTP, 200 nM of each primer, 0.75 U of TripleMaster Poly-
merase Mix (Eppendorf) and 100 ng of genomic DNA. Genomic
DNA, prepared from spores, was ampliﬁed in 50 ll reaction volume
containing 5 ll of 10· reaction buﬀer (Roche Diagnostics GmbH),
100 lM of each dNTP, 200 nM of each primer and 2 U of Taq
DNA polymerase (Roche).
The thermocycle conditions routinely used with Taq DNA polymer-
ase and Expand High Fidelity Enzyme Mix were one cycle at 94 C for
2 min, 30 cycles at 94 C for 30 s, 55 C for 30 s and 72 C for 1 min
(per kb) and one cycle at 72 C for 5 min, and with TripleMaster Poly-
merase Mix were one cycle at 94 C for 2 min, 30 cycles at 94 C for
20 s, 55 C for 20 s and 72 C for 1 min (per kb) and one cycle at
72 C for 3 min. Reactions were carried out in a PC-960, PC-960G
(Corbett Research, Mortlake, Australia), or Mastercycler gradient
(Eppendorf, Hamburg, Germany) thermocycler.2.5. Construction of expression constructs
Plasmid pSS8 (paxG–paxA–paxM–paxB–paxC) was constructed by
ligating into pII99 an 11 kb HindIII fragment containing paxG–
paxA–paxM–paxB–paxC from kCY55.
Plasmid pSS16 (paxG–paxM–paxC) was constructed by ligating into
SpeI digested pSS8 a 2.54 kb SpeI fragment containing paxM. The
fragment was prepared by digesting the PCR product ampliﬁed with
primer set paxMSpeF2 and paxMSpeR from plasmid pSS8. Both
primers contained mismatches relative to the genomic sequences in
order to introduce SpeI sites at both ends.
Plasmid pSS17 (paxG–paxM–paxB–paxC) was constructed by ligat-
ing into SpeI digested pSS8 a 3.4 kb SpeI fragment containing paxM–
paxB. The fragment was prepared by digesting the PCR product
ampliﬁed with primer set paxMSpeR and SS8 from plasmid pSS8.
Primer SS8 contained a native SpeI site.
Plasmid pSS20 (paxG–paxA–paxM–paxC) was constructed by ligat-
ing into SpeI digested pSS8 a 3.94 kb SpeI fragment containing paxA–
paxM. The fragment was prepared by digesting the PCR product
ampliﬁed with primer set paxMSpeF1 and SS9 from genomic DNA.
Primer paxMSpeF1 contained mismatches relative to the genomic se-
quence in order to introduce a SpeI site at one end. Primer SS9 con-
tained a native SpeI site.
2.6. Penicillium paxilli transformations and screening
Protoplasts of PN2250 (CY2) were prepared and transformed with
circular plasmids pSS8, pSS16, pSS17 and pSS20 as described previ-
ously [19], except that the RG medium used for plating protoplasts
was ACM supplemented with 0.8 M sucrose (see above). Transfor-
mants were selected on RG medium supplemented with geneticin
(150 lg/ml) (Roche). The resulting stable transformants were main-
tained on ACM medium.
Screening of transformants for integration of the expression
construct was carried out using genomic DNA from fungal spores
(see above) as template and primer sets (see below) within, and
external to, the gene fragment, to be integrated. The PCR conditions
used were the standard conditions for Taq DNA polymerase (see
above).
2.7. Indole-diterpene analysis
Mycelia from liquid cultures of P. paxilli grown for 7 days in
CDYE, supplemented with trace element mix, were washed and freeze
dried. Indole-diterpenes were extracted in 2:1 chloroform–methanol
mixture. For thin-layer chromatography (TLC) analysis extracts were
concentrated and redissolved in chloroform–methanol (2:1) and frac-
tionated on SIL G (Macherey-Nagel, Germany) TLC plates using
9:1 chloroform–acetone mixture. Indole-diterpenes were identiﬁed
with Ehrlich’s reagent [2% (w/v) p-dimethylaminobenzaldehyde in
12% (v/v) HCl and 50% ethanol]. Analytical HPLC runs were per-
formed on a Dionex Summit (Dionex Corporation, CA, USA) HPLC
system equipped with a Luna (Phenomenex, CA, USA) C18 column
(5 lm particle size, 4.6 · 250 mm). Indole-diterpenes were eluted with
methanol–water (85:15) at a ﬂow rate of 1.5 ml/min and UV detection
at either 230 or 280 nm. LC–MSMS analysis was performed on a
Thermo Finnigan Surveyor (Thermo Finnigan, CA, USA) HPLC sys-
tem equipped with a Luna (Phenomenex) C18 column (5 lm particle
size, 2 · 150 mm) at a ﬂow rate of 200 ll/min with a solvent gradient
starting with acetonitrile–water (60:40) in 0.1% formic acid and
increasing to 95% acetonitrile over 30 min followed by a column wash
at 99% acetonitrile. Mass spectra were determined with linear ion trap
mass spectrometer (Thermo LTQ, Thermo Finnigan, CA, USA) using
electro spray ionization (ESI) in positive mode. The spray voltage was
5.0 kV and the capillary temperature was 275 C. The ﬂow rates of
sheath gas, auxiliary gas and sweep gas were set to 20, 5 and 10 (arbi-
trary units), respectively. Other parameters were optimized automati-
cally by infusing authentic paspaline in water–acetonitrile–formic acid
(75:25:0.1 v:v:v) at a ﬂow rate of 200 ll/min. Paspaline and derivatives
were detected in single reaction monitoring (SRM) mode, selecting 422
m/z ±2, 35% collision energy followed by data-dependent fragmenta-
tion of the three most intense ions in the mass spectrum above a
1000 (arbitrary unit) threshold.2.8. Sequence of primers used in this study
Expression construct primers (restriction sites used for cloning are
underlined and mismatches introduced are shown in bold).
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paxMSpeF2: 5 0 GGACTAGTCCGCTTCTTAGGATCAAC 3 0
paxMSpeR: 5 0 GTACTAGTGTCAGAGTACCCCTCTGC 3 0
For paxM–paxB:
paxMSpeR: 5 0 GTACTAGTGTCAGAGTACCCCTCTGC 3 0
SS8: 5 0 AGACTAGTTTAGATCTTGCAGGATCTCC 3 0
For paxA–paxM:
paxMSpeF1: 5 0 TTACTAGTGATCGGCAGTTGAGGGTG 3 0
SS9: 5 0 TGACTAGTCACAGGTCGTG 3 0
Primers for screening transformants:
pII99-3: 5 0 GGCTGGCTTAACTATGCG 3 0
pII99-4: 5 0 CCCAGAATGCACAGGTAC 3 0
pax64: 5 0 ACTGCATAGTTTGATATCTGC 3 0
pax122: 5 0 GCAGATAGTAGGTACTAC 3 0
pax127: 5 0 GGATTTGACCATGATGCG 3 03. Results and discussion
Constructs containing all or diﬀerent subsets of the ﬁve pax
genes, paxG, paxA, paxM, paxB, and paxC, were cloned into
the geneticin resistant vector pII99 [24] and transformed into
protoplasts of CY2, a paxilline negative deletion mutant
(>100 kb deletion) that lacks the entire pax gene cluster [22]
(Fig. 1). Transformants were initially screened by PCR for
the presence of the construct and then by Southern blot anal-
ysis to conﬁrm integration of a complete copy of the construct
in the recipient strain. The chemical phenotype of the positive
transformants was determined by analyzing chloroform/meth-
anol extracts by TLC and reverse-phase HPLC. A HindIIIFig. 1. (A) Organization of the paxilline (pax) gene cluster. Paspaline
associated genes (black), and other pax genes within the core cluster
(white). The double-headed arrow indicates that the deletion in CY2
includes the entire pax cluster as well as sequences to the left and right
of the cluster. (B) Transformation constructs in linear form showing
the subset of pax genes and the restriction sites used for cloning.
* indicates restriction site introduced by PCR.restriction fragment (11 kb) containing all 5 genes viz. paxG,
paxA, paxM, paxB and paxC was sub-cloned from a lambda
clone, kCY55, into pII99, to generate pSS8. Protoplasts of
CY2 were transformed with pSS8 and an arbitrary selection
of GenR transformants analyzed by TLC for the presence of
indole-diterpenes. Four out of seven CY2/pSS8 transformants
analyzed had a single green-staining compound with an Rf
value similar to that of authentic paspaline (data not shown).
Reverse-phase HPLC analysis of these extracts conﬁrmed that
the compound accumulated had the same retention time
(Rt = 20.5 min) as authentic paspaline (Fig. 2A). Thus, the
introduction of pSS8 into CY2 restored to this strain the abil-
ity to synthesize paspaline. The inability of some of the trans-
formants to produce paspaline, despite containing the ﬁve
genes, could be due to diﬀerences in copy number and/or posi-
tion of integration of the construct in the genome [25]. These
results suggest that ﬁve proteins are suﬃcient for paspaline
biosynthesis. However, the proposed function of the enzymes
PaxG, PaxM and PaxC suggested that these three enzymes
alone might be suﬃcient for paspaline biosynthesis. To test this
hypothesis a plasmid construct pSS16, containing paxG–
paxM–paxC, was prepared by replacing a SpeI fragment con-
taining paxA–paxM–paxB in pSS8 with a PCR ampliﬁed copy
of paxM, and introduced into CY2. However, no detectable
levels of any indole-diterpene were identiﬁed when extracts
from nine of these CY2/pSS16 derivatives were analyzed by
TLC (data not shown) or HPLC (Fig. 2B).
To test whether paxA and/or paxB are necessary for paspa-
line biosynthesis two additional constructs were prepared con-
taining paxG–paxM–paxC and either paxB or paxA. Construct
pSS20 (paxG–paxA–paxM–paxC) was prepared by ligating a
PCR generated paxA–paxM fragment into SpeI digested
pSS8. However, no detectable levels of any indole-diterpene
were identiﬁed when extracts from eight of these CY2/pSS20
derivatives were analyzed by TLC (data not shown) or HPLC
(Fig. 2C).
Construct pSS17 (paxG–paxM–paxB–paxC) was prepared
by ligating a PCR generated paxM–paxB fragment into SpeI
digested pSS8. Four out of ten CY2/pSS17 transformants ana-
lyzed produced a metabolite that eluted at the same retention
time as authentic paspaline (Fig. 2D). In addition to paspaline
(Rt = 20.5 min), a new more polar indole-diterpene (Rt =
10.5 min) was found to accumulate in the extracts of some of
the CY2/pSS17 derivatives (Fig. 2D). This metabolite was
not detected in extracts of wild-type P. paxilli. LC–MSMS
analysis conﬁrmed that two major indole-diterpenes were pres-
ent in extracts from CY2/pSS17 transformant CY2.P17.3
(Fig. 3), both with m/z values of 422. The compound eluting
at 24.2 min (Fig. 3) has a fragmentation pattern consistent
with authentic paspaline whereas that eluting at 15.8 min has
a fragmentation pattern indicative of a partially cyclized in-
dole-diterpene (Supplementary material). The accumulation
of this novel indole-diterpene metabolite may be due to the ab-
sence of the complete paxilline biosynthetic machinery. Prod-
ucts of partial cyclization like emindoles and emeniveol have
been isolated from Emericella species suggesting that alterna-
tive cyclization pathways of indole and diterpene moieties
are possible without skeletal rearrangement [26–29].
Identiﬁcation of the proteins required for paspaline produc-
tion now allows elucidation of the individual biosynthetic steps
involved in its formation. We have shown here that just four
proteins PaxG, PaxM, PaxB and PaxC are required for
Fig. 2. Reverse-phase HPLC traces of CY2 derivatives containing: (A) pSS8 (paxG–paxA–paxM–paxB–paxC), (B) pSS16 (paxG–paxM–paxC), (C)
pSS20 (paxG–paxA–paxM–paxC) and (D) pSS17 (paxG–paxM–paxB–paxC); CY2 – negative control; CY2.V – pII99 vector only control; P8 – pSS8;
P16 – pSS16; P17 – pSS17; P20 – pSS20. The HPLC signal for wild-type is 6% of the original signal.
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of iterative condensations of IPP with DMAPP, GPP, then
FPP, to form GGPP. Although the precise details of the mech-
anism of condensation of the GGPP and indole moiety, and
subsequent epoxidation and cyclization events are not clear,
our data implicate roles for PaxM and PaxC in these steps.
We propose that PaxM, a FAD-dependent monooxygenase,
catalyzes the epoxidation of the two terminal alkenes of the
geranylgeranyl moiety (Fig. 4). Subsequently, PaxC, a prenyl
transferase, catalyzes the cationic cyclization giving rise to
paspaline. The condensation of indole-3-glycerol phosphate
with GGPP may be catalyzed by either PaxG or PaxC.
Although our data clearly demonstrates that PaxB is
required for paspaline biosynthesis, its role in paspaline
biosynthesis is not clear. However, secondary structure analy-
sis suggests that it may be a transporter. Unlike the majorABC (ATP-binding cassette) and MFS (major facilitator
superfamily) fungal transporters, PaxB contains seven
transmembrane domains. Most ABC and MFS transporters
associated with secondary metabolite gene clusters appear to
have a role in self-protection of the producing organism from
the toxic eﬀects of the metabolite [30,31]. Given the novel
structure of PaxB and the indole-diterpene negative phenotype
of the paxB mutant (Monahan et al., unpublished results), we
propose that it is more likely to have a role in transporting sub-
strate(s) to the vicinity of the biosynthetic enzyme complex,
than a role in self-protection. Functional analysis of PaxM,
PaxB and PaxC to conﬁrm these predicted functions is cur-
rently underway as are reporter gene fusion experiments to
localize these proteins in the cell.
In summary,we have successfully demonstrated that four pro-
teins are required for paspaline biosynthesis. On the basis of this
Fig. 3. Chromatogram of CY2/pSS17 (paxG–paxM–paxB–paxC) derivative, strain CY2.P17.3, showing the elution times for paspaline and a novel
indole-diterpene metabolite. Top line: UV trace at 275 nm; Bottom line: LC–MSMS trace showing 422 ions containing 130 m/z fragments
characteristic of indole moiety.
Fig. 4. Proposed scheme for paspaline biosynthesis in P. paxilli.
S. Saikia et al. / FEBS Letters 580 (2006) 1625–1630 1629work, we predict that orthologues of these four genes will be
common to other indole-diterpene biosynthetic gene clusters
including those for aﬂatrem [32] and lolitrem [33] biosynthesis.
We also propose that paspaline is the key intermediate for
indole-diterpene biosynthesis, providing the core structural
backbone for subsequent reactions that generate the chemical
diversity within this important group of secondary metabolites.
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